Neurocrine Biosciences to Present New Quality-of-Life Data Analysis from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia Patients, at the 2019 American Psychiatric Association Annual Meeting - PRNewswire

Submitted by Anonymous (not verified) on Thu, 05/16/2019 - 20:01

Neurocrine Biosciences to Present New Quality-of-Life Data Analysis from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia Patients, at the 2019 American Psychiatric Association Annual Meeting  PRNewswireNew Long-Term Data from the KINECT 4 Study Highlight the Overall Effect of INGREZZA® (valbenazine) Treatment on Abnormal Movements in Patients with ...